Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF.
about
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?CD44v6 dependence of premetastatic niche preparation by exosomesInfluence of the interaction between nodal fibroblast and breast cancer cells on gene expression.Host matrix modulation by tumor exosomes promotes motility and invasiveness.Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastasesBreast cancer stem cells: Multiple capacities in tumor metastasis.Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness.Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Breast cancer stem cells, cytokine networks, and the tumor microenvironment.Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivityInduction of Smad1 by MT1-MMP contributes to tumor growth.Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy.Growth factors in tumor microenvironment.Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling.Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: implication for autologous fat grafting.Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.Exosomal tumor microRNA modulates premetastatic organ cells.Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer.Targeting the tumour stroma to improve cancer therapy.
P2860
Q28081844-7A42EBCE-2F45-4946-A649-C4408359ADDFQ28568064-19E45EBC-689A-4989-A748-C488923BCD24Q30497677-8C8F5BCE-AEAC-4D7D-83E6-0F9CF3E1C404Q30541999-23C50995-640F-4745-BBCF-92E0A60DF961Q33713800-B2BA29F4-E2D5-4774-8EC5-151F85E9C9EBQ34257303-8B91C009-71B9-4D94-BBA4-94943060ED78Q34515871-E811615F-CD35-4489-AB0D-E91398A4E0C0Q34600828-C5E64D91-11DF-443C-B543-153485A80161Q35571904-69A0DADC-09A9-4ADE-90CB-49B2C3F97210Q35757179-32100955-18A7-4147-910B-9DFBE156DD38Q36157381-403FFB67-CB81-4464-95FC-3FFEDBC45C93Q36318551-87D55246-5952-4420-803E-D0D5594068DBQ37663172-83E2E62F-CCDC-4882-8163-A0E37382313EQ37718453-E6E935D3-E175-4798-A4EF-D3C01A661F2CQ37744842-D3021D9E-773B-4240-9ECF-576830968211Q38856698-688F24E2-D18B-4272-91B6-2BB266C86891Q38924893-7174886D-76A4-4C01-933B-1CA2611F7449Q39182484-5CC3A905-A3A8-4645-8D1C-698FA4BA66BBQ40462263-16EB330B-0174-4F5F-91AF-25CEAECAFA0DQ50352443-47D4BF2C-CB93-4715-8EC6-46B5B1A7B67BQ52322982-D5E8DE9C-7A92-44E0-9505-A9EE295A477B
P2860
Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Peripheral lymph node stromal ...... the release of IGF-I and EGF.
@en
type
label
Peripheral lymph node stromal ...... the release of IGF-I and EGF.
@en
prefLabel
Peripheral lymph node stromal ...... the release of IGF-I and EGF.
@en
P2093
P2860
P356
P1476
Peripheral lymph node stromal ...... the release of IGF-I and EGF.
@en
P2093
Christina LeBedis
Keguan Chen
Lucia Fallavollita
Pnina Brodt
Tarek Boutros
P2860
P356
10.1002/IJC.10481
P577
2002-07-01T00:00:00Z